Skip to main content

Table 1 Differences in mortality and co-morbidity amongst males and females testing positive for Covid-19

From: Increasing adiposity and the presence of cardiometabolic morbidity is associated with increased Covid-19-related mortality: results from the UK Biobank

  Male Female Odds ratio (95% CI) P
N 835 747
Died (n) 200 105 1.93 (1.49–2.51) < 0.0001
Age (mean years ± SD) 69 ± 9 66 ± 9 < 0.0001
BMI (kg/m2, mean ± SD 28.9 ± 4.8 28.6 ± 6.1 0.32
Hypertension (n) 343 226 1.61 (1.31–1.98) < 0.0001
Dyslipidaemia (n) 206 97 2.20 (1.68–2.86) < 0.0001
Atrial fibrillation (n) 109 35 3.05 (2.06–4.58) < 0.0001
Ventricular arrhythmia (n) 9 1 8.13 (1.36–89.41) 0.02
Diabetes (n) 150 74 1.99 (1.47–2.70) < 0.0001
Stroke (n) 20 15 1.20 (0.63–2.29) 0.61
Angina (n) 123 54 2.21 (1.58–3.08) < 0.0001
  1. Male participants testing positive have a higher odds ratio for mortality than their female counterparts. Males testing positive were older and had a greater comorbidity, although there was no difference in BMI or history of stroke between sexes. Age and BMI were treated as continuous variables and compared between sexes using T test. All other variables were treated as categorical and compared using Fisher’s exact test